Von Willebrand factor's clearance

被引:0
|
作者
Denis, Cecile V. [1 ]
Lenting, Peter J. [2 ]
机构
[1] INSERM, Unite 143, 80 Rue General Leclerc, F-94276 Le Kremlin Bicetre, France
[2] Univ Med Ctr Utrecht, Dept Haematol, Lab Thrombosis & Haemostasis, Utrecht, Netherlands
来源
HEMATOLOGIE | 2006年 / 12卷 / 01期
关键词
von Willebrand factor; von Willebrand disease; clearance; gene modifier; mutations; in vivo models;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand factor (FVW) is a multimeric plasma glycoprotein that plays two major roles in hemostasis: it promotes platelet adhesion to the subendothelium in case of vascular injury and it carries and protects coagulation FVIII in the circulation. FVW plasma concentration requires tight regulation since a reduced level may result in a bleeding tendency whereas an elevated concentration is associated with an increased thrombotic risk. Plasma levels represent a balance between biosynthetic and catabolic pathways. With regard to FVW, its biosynthetic pathways has been well studied in the past while relatively little is known concerning its clearance mechanism. However, recent data point to abnormal clearance as being a potential cause for von Willebrand disease, the most common inherited bleeding disorder in humans. Defective clearance may originate from a variety of reasons: mutations in the FVW gene, effect of a gene modifier or increase functionality of the FVW clearance mechanism. In this review, we will give an update of the present knowledge on how FVW is cleared from the circulation and how this process is regulated.
引用
收藏
页码:34 / 43
页数:10
相关论文
共 50 条
  • [41] von Willebrand factor clearance does not involve proteolysis by ADAMTS-13
    Badirou, I.
    Kurdi, M.
    Rayes, J.
    Legendre, P.
    Christophe, O. D.
    Lenting, P. J.
    Denis, C. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (10) : 2338 - 2340
  • [42] VON WILLEBRAND FACTOR AND ITS EFFECT ON FVIII CLEARANCE IN PERIOPERATIVE HEMOPHILIA A PATIENTS
    Van Moort, I.
    Bukkems, L. H.
    Heijdra, J. H.
    Schutgens, R.
    Laros-van Gorkom, B.
    Nieuwenhuizen, L.
    van der Meer, F. J.
    Fijnvandraat, K.
    Ypma, P.
    Eikenboom, J.
    de Maat, M. P.
    Leebeek, F. W.
    Mathot, R. A.
    Cnossen, M. H.
    HAEMOPHILIA, 2020, 26 : 84 - 85
  • [43] Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test
    Mori, Filippo
    Rossi, Paola
    Nardini, Ilaria
    Gambelli, Davide
    Farina, Claudio
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 221 - 228
  • [44] Increased galactose expression and enhanced clearance in patients with low von Willebrand factor
    Aguila, Sonia
    Lavin, Michelle
    Dalton, Niall
    Patmore, Sean
    Chion, Alain
    Trahan, George D.
    Jones, Kenneth L.
    Keenan, Catriona
    Brophy, Teresa M.
    O'Connell, Niamh M.
    Ryan, Kevin
    Byrne, Mary
    Nolan, Margaret
    Patel, Anjali
    Preston, Roger J. S.
    James, Paula
    Di Paola, Jorge
    O'Sullivan, Jamie M.
    O'Donnell, James S.
    BLOOD, 2019, 133 (14) : 1585 - 1596
  • [45] Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis
    Lin, SM
    Yeh, JH
    Lee, CC
    Chiu, HC
    JOURNAL OF CLINICAL APHERESIS, 2003, 18 (02) : 67 - 70
  • [46] RETROSPECTIVE REVIEW OF FOUR DAYS OF VON WILLEBRAND'S FACTOR AS SURGICAL PROPHYLAXIS IN VON WILLEBRAND'S DISEASE
    Bal, S.
    Riaz, M. K.
    Peters, D.
    Palascak, J.
    Girnius, S.
    HAEMATOLOGICA, 2017, 102 : 401 - 402
  • [47] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [48] Von Willebrand factor binding to heparin in von Willebrand disease
    Rastegar-Lari, G
    Legendre, P
    Ajzenberg, N
    Meyer, D
    Baruch, D
    THROMBOSIS AND HAEMOSTASIS, 1999, : 510 - 511
  • [49] Von Willebrand Factor and von Willebrand disease: prerequisite for diagnostic
    Fressinaud, Edith
    HEMATOLOGIE, 2014, 20 : 6 - 13
  • [50] von Willebrand disease and quantitative variation in von Willebrand factor
    Mohlke, KL
    Ginsburg, D
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03): : 252 - 261